Sumo Logic Q2 Results Exceed Street Expectations

 

 

  • Sumo Logic Inc (NASDAQ:SUMO) reported a second-quarter FY23 revenue increase of 26% year-over-year to $74.1 million, beating the consensus of $71.54 million.
  • Annual Recurring Revenue (“ARR”) increased by 25% Y/Y to $286.2 million.
  • Adjusted EPS was $(0.10), beating the consensus of $(0.11).
  • The gross margin contracted to 65% from 66% in 2Q21. Adjusted gross margin was 70%, down by 200 bps.
  • Adjusted operating loss for the quarter was $12.69 million, compared to $12.42 million a year ago.
  • Net cash used in operating activities for the six months ended July 31, 2022, totaled $13.44 million, compared to $7.26 million a year ago. Free cash outflow was $14.43 million.
  • The company held cash and cash equivalents and marketable securities of $350.6 million as of July 31, 2022
  • 3Q23 Outlook: Sumo Logic expects Total revenue of $73.5 million – $74.5 million, vs. a consensus of $73 million.
  • It expects a Non-GAAP operating margin of (24)% to (23)% and a Non-GAAP net loss per share of $0.15.
  • FY23 Outlook: The company expects Total revenue of $289.0 million – $293.0 million, vs. a consensus of $290.4 million.
  • It sees a Non-GAAP operating margin of (23)% to (22)% and Non-GAAP net loss per share of $0.56 to $0.54.
  • Price Action: SUMO shares are trading lower by 0.81% at $8.51 during the post-market session on Thursday.
  •  

 

 

 

Total
0
Shares
Related Posts
Read More

Curated Strains And Branded Cannabis Gear By The Cannabist And Revelry Launching In Four East Coast Markets

The Cannabist Company Holdings Inc. is expanding its partnership with Revelry Herb Co., an artisan-quality flower and pre-roll brand launched by the creators of Revelry Supply. The expansion into the Maryland, Ohio, Pennsylvania and New York markets follows a recent collaboration in New Jersey and Massachusetts, Jesse Channon, president of The Cannabist Company, said. "We've experienced remarkable success with Revelry in just a short amount of time since launching in New Jersey and Massachusetts and the feedback we are getting from our patients and customers has been off the charts," Channon said. "We are especially honored to be their trusted cultivation, production and manufacturing partner delivering top-quality flower strains from our facilities across all our markets for this expansion."

CBSTF